Linzess and Tumor - a phase IV clinical study of FDA data

Summary:

Tumor is reported as a side effect among people who take Linzess (linaclotide), especially for people who are female, 60+ old, also take Lipitor, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Tumor when taking Linzess. It is created by eHealthMe based on reports of 23,558 people who have side effects when taking Linzess from the FDA, and is updated regularly.

What is Linzess?

Linzess has active ingredients of linaclotide. It is often used in constipation. eHealthMe is studying from 24,086 Linzess users. Check the latest studies of Linzess.

What is Tumor?

Tumor is found to be associated with 1,407 drugs and 1,707 conditions by eHealthMe. Check the latest studies of Tumor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

23,558 people reported to have side effects when taking Linzess.
Among them, 22 people (0.09%) have Tumor.

Among these 22 people:

What is the gender of people who have Tumor when taking Linzess? *

female: 86.36 %
male: 13.64 %

What is the age of people who have Tumor when taking Linzess? *

What are other drugs people take besides Linzess? *

What are other side effects people have besides Tumor? *

Fatigue (feeling of tiredness): 10 people, 45.45%
Abdominal Distension: 7 people, 31.82%
Sinusitis (inflammation of sinus): 7 people, 31.82%
Back Pain: 6 people, 27.27%
Infusion Related Reaction: 6 people, 27.27%
Peripheral Swelling: 6 people, 27.27%
Scar: 5 people, 22.73%
Viral Infection: 5 people, 22.73%
Drowsiness: 5 people, 22.73%
Infusion Site Pain: 5 people, 22.73%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 6 people, 27.27%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 9.09%
Multiple Myeloma (cancer of the plasma cells): 2 people, 9.09%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 4.55%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 4.55%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 1 person, 4.55%
Gait Disturbance: 1 person, 4.55%
Immunodeficiency: 1 person, 4.55%
Migraine (headache): 1 person, 4.55%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Linzess and have Tumor?

- Check whether Tumor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Linzess:

Linzess (24,086 reports)

Tumor treatments and more:

Tumor (38,734 reports)

Browse all side effects of Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tumor:

Tumor (1,407 drugs)

Browse all the conditions that are associated with Tumor:

Tumor (1,707 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on linaclotide (the active ingredients of Linzess) and Linzess (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.